pubmed.ncbi.nlm.nih.gov

Obesity, inflammation, and liver cancer - PubMed

Review

Obesity, inflammation, and liver cancer

Beicheng Sun et al. J Hepatol. 2012 Mar.

Abstract

Obesity has become a universal and major public health problem with increasing prevalence in both adults and children in the 21st century, even in developing countries. Extensive epidemiological studies reveal a strong link between obesity and development and progression of various types of cancers. The connection between obesity and liver cancer is particularly strong and obesity often results in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH). NASH is characterized by fatty liver inflammation and is believed to cause fibrosis and cirrhosis. The latter is a known liver cancer risk factor. In fact due to its much higher prevalence obesity may be a more substantial contributor to overall hepatocellular carcinoma burden than infection with hepatitis viruses. Here we review and discuss recent advances in elucidation of cellular and molecular alterations and signaling pathways associated with obesity and liver inflammation and their contribution to hepatocarcinogenesis.

PubMed Disclaimer

Figures

**Figure 1**
Three putative mechanisms for obesity-induced and obesity-promoted hepatocarcinogenesis. ROS, reactive oxygen species; RNS, reactive nitrogen species

**Figure 2**
Adipokines, cytokines and hepatocarcinogenesis. Excessive free fatty acids (FFAs) can activate various immune cells and cause hepatocytes cell death. Moreover, cell debris, pro-inflammatory cytokines and adipokines can further enhance TNF and IL-6 secretion from Kupffer cells, leading to activation of downstream signaling molecules, such as STAT3 in hepatocytes which contribute to hepatocarcinogenesis.

Cited by

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, Deng L, Huang X, Wang K, Sun B. Zhang W, et al. Oncotarget. 2015 Apr 20;6(11):9420-33. doi: 10.18632/oncotarget.3353. Oncotarget. 2015. PMID: 25826083 Free PMC article.
The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis.
Simoni-Nieves A, Salas-Silva S, Chávez-Rodríguez L, Escobedo-Calvario A, Desoteux M, Bucio L, Souza V, Miranda-Labra RU, Muñoz-Espinosa LE, Coulouarn C, Gutiérrez-Ruiz MC, Marquardt JU, Gomez-Quiroz LE. Simoni-Nieves A, et al. Cancers (Basel). 2021 Apr 6;13(7):1721. doi: 10.3390/cancers13071721. Cancers (Basel). 2021. PMID: 33917315 Free PMC article.
CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis.
Vonghia L, Ruyssers N, Schrijvers D, Pelckmans P, Michielsen P, De Clerck L, Ramon A, Jirillo E, Ebo D, De Winter B, Bridts C, Francque S. Vonghia L, et al. Mediators Inflamm. 2015;2015:239623. doi: 10.1155/2015/239623. Epub 2015 Jul 1. Mediators Inflamm. 2015. PMID: 26229237 Free PMC article.
Trends in liver cancer mortality in China from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.
Chen T, Zhang Y, Liu J, Rao Z, Wang M, Shen H, Zeng S. Chen T, et al. BMJ Open. 2023 Dec 30;13(12):e074348. doi: 10.1136/bmjopen-2023-074348. BMJ Open. 2023. PMID: 38159955 Free PMC article.
Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model.
Shimizu Y, Tamura T, Kemmochi A, Owada Y, Ozawa Y, Hisakura K, Matsuzaka T, Shimano H, Nakano N, Sakashita S, Oda T, Ohkohchi N. Shimizu Y, et al. J Gastroenterol Hepatol. 2021 Mar;36(3):800-810. doi: 10.1111/jgh.15239. Epub 2020 Oct 5. J Gastroenterol Hepatol. 2021. PMID: 32870526 Free PMC article.

References

1. Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med. 2002;346:854–855. - PubMed
1. Haslam DW, James WP. Obesity. Lancet. 2005;366:1197–1209. - PubMed
1. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology. 2002;36:150–155. - PubMed
1. Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl. 2004;10:S69–73. - PubMed
1. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127:S97–103. - PubMed

Obesity, inflammation, and liver cancer - PubMed